Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-132,300
Closed -$1.85M 5949
2024
Q3
$1.85M Buy
+132,300
New +$1.46M ﹤0.01% 3767

Other funds holding AXGN

Israel Englander's AXGN Position: Q2 2026 in Review

Israel Englander reduced its Axogen (AXGN) stake by 97% in Q2 2026, selling an estimated $30.6M and leaving 27,240 shares worth $1.26M. The position accounts for ﹤0.01% of the portfolio, ranked #4169.

Israel Englander first reported a position in AXGN in Q1 2016 and has held it in 34 quarters since. The position peaked at $31.8M in Q4 2025. 251 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • Israel Englander held 27,240 shares of Axogen worth $1.26M as of Q2 2026.
  • Israel Englander sold 760,014 Axogen shares in Q2 2026, an estimated $30.6M.
  • Axogen made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #4169 holding.
  • Israel Englander first reported a position in Axogen in Q1 2016 and has held it in 34 quarters since.
  • Israel Englander's Axogen position peaked at $31.8M in Q4 2025.
  • 251 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.